Fig. 2: Epidemiologic stages of IBD across global regions.
From: The global burden of inflammatory bowel disease: from 2025 to 2045

A machine learning model classified epidemiologic stages across global regions, defining coalescing incidence ranges (25th–75th percentiles) (part a) and coalescing prevalence ranges (25th–75th percentiles) for IBD (part b) across stage 1, stage 2 and stage 3 (ref. 4). Data source and availability: https://kaplan-gi.shinyapps.io/GIVES21.